Haemonetics (NYSE:HAE) announced today that it received FDA approval to expand the labeling for its Vascade MVP XL system. Expanded labeling includes procedures using 10-14F inner diameter (ID) and up to 17F outer diameter (OD) procedural sheaths. This grants Vascade MVP XL approval for larger sheaths used in market-leading technologies used for … [Read more...] about Haemonetics wins expanded FDA nod for vascular closure system in PFA, LAAC to treat AFib
Haemonetics
Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
Haemonetics (NYSE: HAE) announced today that it acquired percutaneous vessel closure device maker Vivasure Medical. Galway, Ireland-based Vivasure develops the PerQSeal Elite system, the first sutureless, fully absorbable synthetic implant for large-bore vessel punctures. Placement occurs from inside the vessel. It makes deployment simpler and … [Read more...] about Haemonetics acquires Irish vessel closure company Vivasure for $116.4M
Haemonetics wins CE mark for Vascade vascular closure device
Haemonetics today announced it received CE mark approval for its Vascade vascular closure and Vascade MVP venous vascular closure systems. The CE mark approval will allow the Boston-based company to enter specific markets in the European Union, as well as other regions that recognize the regulatory marking. Haemonetics designed the Vascade … [Read more...] about Haemonetics wins CE mark for Vascade vascular closure device
